can you workout while on semaglutide GLP-1 and Exercise: What Need to Know Does Walking Help with Fat

These studies provide a solid foundation for recommending GLP-1 therapies

Product: KLOW

De Silva A, Salem V, Long CJ, Makwana A, Newbould RD, Rabiner EA, et al

The American Diabetes Association (ADA) guidelines recognize GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who require additional glucose-lowering therapy beyond metformin, particularly those with established cardiovascular disease or chronic kidney disease, with preference given to agents with proven cardiovascular benefit

Up to 50% of patients with GBP present with hypoglycaemia at some point, most of them asymptomatic

Thus, GLP-1 signaling represents a promising target for PD treatment